Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ovarian Neoplasms

Free Subscription Articles published in Oncogene Retrieve available abstracts of 43 articles: HTML format Text format

Single Articles

January 2012
1. JEONG KJ , Park SY, Cho KH, Sohn JS, et al
   The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
   Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ZELLER C , Dai W, Steele NL, Siddiq A, et al
   Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.
   Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. ALBERTI C , Pinciroli P, Valeri B, Ferri R, et al
   Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
   Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. RATNER ES , Keane FK, Lindner R, Tassi RA, et al
   A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.
   Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
5. CAO L , Shao M, Schilder J, Guise T, et al
   Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
   Oncogene. 2011 Oct 3. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
6. WANG Y , Sheng Q, Spillman MA, Behbakht K, et al
   Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.
   Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. YUE P , Zhang X, Paladino D, Sengupta B, et al
   Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.
   Oncogene. 2011 Sep 12. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
8. ZHANG Y , Cheng Y, Ren X, Zhang L, et al
   NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
   Oncogene. 2011 Jul 11. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. CHAO A , Lin CY, Lee YS, Tsai CL, et al
   Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
   Oncogene. 2011 Jul 4. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
10. LAU MT , Klausen C, Leung PC
    E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression.
    Oncogene. 2011;30:2753-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. BADGWELL DB , Lu Z, Le K, Gao F, et al
    The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
12. FU G , Peng C
    Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
13. REIMER D , Hubalek M, Kiefel H, Riedle S, et al
    Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
14. AL-BAHLANI S , Fraser M, Wong AY, Sayan BS, et al
    P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
15. ZHAI Y , Iura A, Yeasmin S, Wiese AB, et al
    MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CHENG JC , Auersperg N, Leung PC
    Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KIM JH , Yoon S, Park M, Park HO, et al
    Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
    Oncogene. 2011;30:1653-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
18. MULLANY LK , Fan HY, Liu Z, White LD, et al
    Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. CHAROENFUPRASERT S , Yang YY, Lee YC, Chao KC, et al
    Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
20. CHEN X , Zhang H, Aravindakshan JP, Gotlieb WH, et al
    Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated gene OTAG-12: downregulation, alternative splicing and drug sensitization.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. CHEUNG LW , Mak AS, Cheung AN, Ngan HY, et al
    P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. ZHANG X , George J, Deb S, Degoutin JL, et al
    The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
23. IP CK , Cheung AN, Ngan HY, Wong AS, et al
    p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. PINEIRO R , Maffucci T, Falasca M
    The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.
    Oncogene. 2011;30:142-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
25. MITRA AK , Sawada K, Tiwari P, Mui K, et al
    Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. PONNUSAMY MP , Lakshmanan I, Jain M, Das S, et al
    MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.
    Oncogene. 2010;29:6084.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
27. CHENG JC , Auersperg N, Leung PC
    Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
28. HE X , Arslan AD, Pool MD, Ho TT, et al
    Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
29. INGEMARSDOTTER CK , Baird SK, Connell CM, Oberg D, et al
    Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. PONNUSAMY MP , Lakshmanan I, Jain M, Das S, et al
    MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
31. GONCHARENKO-KHAIDER N , Lane D, Matte I, Rancourt C, et al
    The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
32. COOKE SL , Ng CK, Melnyk N, Garcia MJ, et al
    Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
33. LANE D , Goncharenko-Khaider N, Rancourt C, Piche A, et al
    Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. YIN G , Chen R, Alvero AB, Fu HH, et al
    TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
35. HEINRICH C , Keller C, Boulay A, Vecchi M, et al
    Copine-III interacts with ErbB2 and promotes tumor cell migration.
    Oncogene. 2010;29:1598-610.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. RATTAN R , Narita K, Chien J, Maguire JL, et al
    TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathway.
    Oncogene. 2010;29:1362-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. GAO MQ , Choi YP, Kang S, Youn JH, et al
    CD24(+) cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
38. CHEUNG LW , Leung PC, Wong AS
    Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
39. PENG S , Maihle NJ, Huang Y
    Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. HOFSTETTER G , Berger A, Fiegl H, Slade N, et al
    Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. YAMAGUCHI K , Mandai M, Oura T, Matsumura N, et al
    Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2009
42. LEVANON K , Ng V, Piao HY, Zhang Y, et al
    Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2009
43. WOLF I , Laitman Y, Rubinek T, Abramovitz L, et al
    Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: